Legend Biotech Corp - ADR

Legend Biotech Corp - ADR

LEGN

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.77B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Legend Biotech Corp - ADRLegend Biotech Corp - ADR-40.7--7%3.40.2
$53.78

Target Price by Analysts

165.3% upsideLegend Biotech Target Price DetailsTarget Price

Share Statistics

Market cap$3.77 Billion
Enterprise Value$3.37 Billion
Dividend Yield$- (-)
Earnings per Share$-1.6
Beta0.37
Outstanding Shares187,000,112

Return

Return on Equity-7.48%ROE
Return on Assets-5.25%
Return on Invested Capital-3.16%

Valuation & Multiples

P/E Ratio-40.74P/E Ratio
PEG32.23PEG
Price to Sales3.38Price to Sales
Price to Book Ratio3.38Price to Book Ratio
Enterprise Value to Revenue2.65
Enterprise Value to EBIT-79.24
Enterprise Value to Net Income-37
Total Debt to Enterprise0.08
Debt to Equity0.23Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$0.07
Average shareholder expectation
Revenue Estimate
$355.96 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 17, 2026
EPS Estimate
$0.01
Average shareholder expectation
Revenue Estimate
$361.43 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.0000 27.79%
Total Calls72,000 87.35%
Total Puts72,000 82.48%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.29% 44.37%
Total Invested$389.07M 77.46%
Investors Holding82 125.00%

ESG Score

No data

About Legend Biotech Corp